Exercise Cuts Cardiac Events in Non-Metastatic Breast Cancer

This article originally appeared here.
Share this content:
Exercise Cuts Cardiac Events in Non-Metastatic Breast Cancer
Exercise Cuts Cardiac Events in Non-Metastatic Breast Cancer

TUESDAY, June 7, 2016 (HealthDay News) -- For patients with non-metastatic breast cancer, exercise is associated with reductions in the incidence of cardiovascular events, according to a study published online May 23 in the Journal of Clinical Oncology.

Lee W. Jones, Ph.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a prospective study involving 2,973 women diagnosed with non-metastatic breast cancer. Participants completed a questionnaire that assessed leisure-time recreational physical activity, measured in metabolic equivalent task-hours/week (MET-h/wk). Patients were followed for a median of 8.6 years.

The researchers found that the incidence of cardiovascular events decreased across increasing total MET-h/wk categories, in multivariable analysis (Ptrend < 0.001). Compared with <2 MET-h/wk, for 2 to 10.9, 11 to 24.5, and ≥24.5 MET-h/wk the adjusted hazard ratios were 0.91 (95 percent confidence interval [CI], 0.76 to 1.09), 0.79 (95 percent CI, 0.66 to 0.96), and 0.65 (95 percent CI, 0.53 to 0.80), respectively. Trends were similar for coronary artery disease and heart failure incidence (P values < 0.05). For adult patients with cancer, adherence to national exercise guidelines versus nonadherence correlated with an adjusted 23 percent reduction in the risk of cardiovascular events (P < 0.001). The correlation was not affected by age, cardiovascular disease risk factors, menopausal status, or anticancer treatment.

"Exercise is associated with substantial, graded reductions in the incidence of cardiovascular events in women with non-metastatic breast cancer," the authors write.

Several authors disclosed financial ties to the pharmaceutical and exercise industries.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »